Ascendis raises $60M series D

Prodrug technology developer Ascendis Pharma A/S (Copenhagen, Denmark) raised $60 million in a series D round led by Sofinnova Ventures; OrbiMed; and Vivo Capital. Janus Capital; Venrock; RA Capital; Rock Springs Capital; and Sectoral Asset Management also participated, as did Sofinnova Partners, Ascendis' largest shareholder. ...